血液恶性瘤中的肝脏:淋巴瘤,白血病和髓瘤
Natalia Zbib1, Maya Gambarin-Gelwan2
1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Gastroenterology, Hepatology and Nutrition Service, Department of Medicine, Memorial Sloan Kettering Cancer Center.
Clinics in liver disease
|July 16, 2025
概括
肝病复杂化了血液恶性瘤和骨髓移植 (BMT). 抗病毒治疗和查对于管理肝脏并发症和改善这些脆弱人群中的患者存活率至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 肝病在患有血液性恶性瘤的患者中存在重大挑战,包括淋巴瘤,白血病和多发性髓瘤.
- 慢性病毒性肝炎 (乙型和乙型肝炎) 增加了治疗风险,并且可以在化疗期间重新激活.
- 骨髓移植 (BMT) 引入了肝脏并发症的重大风险.
研究的目的:
- 突出肝病和血液性恶性瘤之间的关键相互作用.
- 强调抗病毒疗法在减轻癌症患者与病毒性肝炎相关的风险方面的作用.
- 强调主动管理肝脏并发症的战略的重要性.
主要方法:
- 对血液性恶性瘤肝病研究的文献综述.
- 分析慢性乙肝和肝对癌症治疗的影响.
- 检查BMT后的肝脏并发症及其管理.
主要成果:
- 慢性乙型肝炎和型肝炎感染使治疗复杂化,并增加了血液恶性瘤患者的风险.
- 骨髓移植与肝脏并发症有关,需要专门的护理.
- 抗病毒疗法在降低风险和提高生存率方面已显示出有效性.
结论:
- 对肝病的查和预防性抗病毒治疗对于治疗血液恶性瘤患者至关重要.
- 有效管理肝脏相关并发症,包括BMT后的并发症,对于患者的治疗结果至关重要.
- 解决肝脏健康问题是接受血液癌症治疗的个体综合护理的关键组成部分.
相关概念视频
Role of Hematopoietic Growth Factors
1.7K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.7K
Liver Physiology
1.3K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.3K
Bone Marrow Sampling and Transplants
502
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
502
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Overview of Hematopoiesis
4.8K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.8K
Disorders of Leukocytes
1.2K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.2K


